Rabeximod ( —— )

产品货号. M34686 CAS No. 872178-65-9

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

Rabeximod
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models. Rabeximod inhibits arthritis in a time-dependent manner by stimulating TLR2 and TLR4 downstream to block the activation of inflammatory cells, most likely macrophages. Rabeximod effectively reduces brain antigen presentation in mice during anti-inflammatory therapy for traumatic brain injury.
产品描述

Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models. Rabeximod inhibits arthritis in a time-dependent manner by stimulating TLR2 and TLR4 downstream to block the activation of inflammatory cells, most likely macrophages. Rabeximod effectively reduces brain antigen presentation in mice during anti-inflammatory therapy for traumatic brain injury.
体外实验

——
体内实验

——
同义词

——
通路

Immunology/Inflammation
靶点

TLR
受体

TLR
研究领域

——
适应症

——

计算器

产品手册

关联产品

Tomaralimab

Tomaralimab (OPN-305) 是一种人源化的抗-TLR2 (anti-TLR2) IgG4 单克隆抗体。Tomaralimab 具有研究骨髓增生异常综合征 (MDS) 的潜力。
RS09 2TFA 1449566-36...

RS09 2TFA 是一种 TLR4 激动剂。在体外促进 RAW264.7 巨噬细胞中 NF-κB 核转位并诱导炎症细胞因子分泌。它在体内充当佐剂并增强 X-15 特异性抗体血清浓度。
TLR4-IN-C34

TLR4-IN-C34 是一种口服活性 TLR4 抑制剂，可减少内毒素血症和坏死性小肠结肠炎模型中的全身炎症。